A 68-week phase 3 trial found that coadministered cagrilintide and semaglutide led to significant and clinically meaningful ...

Semaglutide improved time spent in glycemic range, time below rate and reduced body weight with low rates of hypoglycemia ...

A new clinical trial found that taking a popular diabetes and weight-loss drug once weekly significantly improves blood sugar ...

Novo Nordisk has ended its collaboration with Hims & Hers Health for its Wegovy weight-loss blockbuster treatment roughly a month after it began over concerns about what it said was illegal mass ...

Mounjaro offers up to 20% weight loss – but it’s not for everyone. Learn about eligibility, alternatives and why long-term ...

Novo Nordisk has ended its collaboration with Hims & Hers Health for its Wegovy weight-loss blockbuster treatment roughly a month after it began over concerns about what it said was illegal mass ...

With weight-loss injections like Semaglutide gaining popularity, experts warn they’re not a one-size-fits-all fix. We got in touch with an expert who explains why long-term success lies in combining ...

THEY are arguably the biggest medical breakthrough of recent times. And from Monday, so-called ‘fat jabs’ will be made ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

CagriSema is a once-weekly injection of semaglutide and cagrilintide. Clinical trial results for CagriSema showed significant improvements in A1C, weight loss, and time in range, marking it as a ...